Followers | 14 |
Posts | 1446 |
Boards Moderated | 0 |
Alias Born | 02/28/2011 |
Wednesday, July 05, 2017 11:04:01 AM
As for cash and funding of Phase 3 - You're correct about the cash 2 million burn rate and 8.3 million at the end of the first quarter. I agree and that I'd rather see dilution in the short term to raise capital to fund the Phase III trial. Given the company's financial track record, they haven't taken loans or partnered with a large company for funding. I expect them to use to dilution or maybe we'll get lucky and they'll receive another grant. It does concern me about funding since we've heard nothing. The IIA 2 million grant was huge but we need just a little more. I'm not sure about the cost of funding the Phase III but I suspect you're accurate to say $10 million. I thought I heard that number during a company update. I think the company's effort to go on the road and give multiple presentations at biotech investor conferences was to bump the share price up. I think it worked at first but since then it's cooled off.
Looking forward - As a long term investor, the only short term PR or information on my wish list is the following.. haha.
1. I hope they release information stating that Phase III is fully funded and when it officially starts.
Future PR's that'll help;
2. Leading into 2018, I hope they gain approval for treatment in Canada. This would provide instant revenue while they're compiling Phase III results.
Media Coverage - The ice bucket challenge was a huge success and if they have positive Phase III results, that alone will bump the stock up.. FDA approval, I can't imagine where this would trade. Some have speculated $12 but FDA approval would spark a huge emotional response and it would go much higher.
Recent BCLI News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 12:00:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2024 08:05:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2024 12:00:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/30/2024 04:15:16 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2024 08:30:28 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/24/2024 08:30:50 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 09/17/2024 07:32:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 08:36:41 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/28/2024 09:01:02 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/16/2024 11:00:19 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 12:01:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 11:15:21 AM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 08/06/2024 08:59:18 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 08/05/2024 09:11:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 08:05:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/24/2024 08:05:18 PM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM
Integrated Ventures, Inc Reports Total 2024 Revenues Of $5,863,935 vs $3,862,849 for 2023. • INTV • Oct 1, 2024 9:00 AM
Nightfood Signs Letter of Intent to Acquire Los Angeles Cooking School, Integrating Automation and Robotics with World-Class Culinary Training • NGTF • Oct 1, 2024 8:30 AM
ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • COOP • Oct 1, 2024 7:00 AM
Element79 Gold Corp secures loi for launching tailings reprocessing business in Arequipa, Peru • ELMGF • Oct 1, 2024 6:38 AM